Back to today’s briefing

Story perspectives

Diabetes Drug Cuts Migraine Days by Over 50%

6/22/2025

41 5

Summary

Story summary

A groundbreaking study at the European Academy of Neurology Congress revealed that liraglutide, a diabetes medication, slashed monthly migraine days by more than 50% in 26 obese adults suffering from chronic migraines. Researchers suggest this remarkable relief is linked to reduced cerebrospinal fluid pressure rather than weight loss, paving the way for future trials on other GLP-1 drugs for migraine treatment.

1 of 1

Story summary

A groundbreaking study at the European Academy of Neurology Congress revealed that liraglutide, a diabetes medication, slashed monthly migraine days by more than 50% in 26 obese adults suffering from chronic migraines. Researchers suggest this remarkable relief is linked to reduced cerebrospinal fluid pressure rather than weight loss, paving the way for future trials on other GLP-1 drugs for migraine treatment.